This prospective case-control study investigated the impact of severe acute respiratory syndrome coronavirus 2 infection on inflammatory bowel disease course and looked for risk factors associated with flares. In the severe acute respiratory syndrome coronavirus 2 pandemic era, inflammatory bowel disease course is not influenced by infection, while therapy discontinuation is a risk factor for disease flare.
IBD FLARE IN THE COVID-19 PANDEMIC: THERAPY DISCONTINUATION IS TO BLAME.
L. Grossi
;
2023-01-01
Abstract
This prospective case-control study investigated the impact of severe acute respiratory syndrome coronavirus 2 infection on inflammatory bowel disease course and looked for risk factors associated with flares. In the severe acute respiratory syndrome coronavirus 2 pandemic era, inflammatory bowel disease course is not influenced by infection, while therapy discontinuation is a risk factor for disease flare.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
IBD 2023 Bezzio.pdf
accesso aperto
Tipologia:
PDF editoriale
Dimensione
135.14 kB
Formato
Adobe PDF
|
135.14 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
